3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC)

作者: J.L. van Laethem , J.L. Raoul , F. Ciardiello , P. Lebrun , P. Rougier

DOI: 10.1016/S1359-6349(07)70929-1

关键词:

摘要:

参考文章(0)